Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer?

This publication has 12 references indexed in Scilit:

• Preoperative Staging of Non–Small-Cell Lung Cancer with Positron-Emission Tomography
  New England Journal of Medicine, 2000
• A threshold method to improve standardized uptake value reproducibility
  Nuclear Medicine Communications, 2000
• Prognostic Importance of the Standardized Uptake Value on ¹⁸F-Fluoro-2-Deoxy-Glucose–Positron Emission Tomography Scan in Non–Small-Cell Lung Cancer: An Analysis of 125 Cases
  Journal of Clinical Oncology, 1999
• PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma
  The Annals of Thoracic Surgery, 1999
• Pulmonary abnormalities and PET data analysis: a retrospective study.
  Radiology, 1997
• Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography
  European Journal of Nuclear Medicine and Molecular Imaging, 1996
• Fluorodeoxyglucose-Positron Emission Tomography in the Detection and Staging of Lung Cancer
  American Journal of Respiratory and Critical Care Medicine, 1996
• Staging non—small cell lung cancer by whole-body positron emission tomographic imaging
  The Annals of Thoracic Surgery, 1995
• CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group.
  Radiology, 1991
• The value of mediastinoscopy in preoperative staging of bronchogenic carcinoma
  The Journal of Thoracic and Cardiovascular Surgery, 1989